TLR3 and Alzheimer disease: According to the results of this study, a modality to inhibit TLR3 signaling or upregulate ΔNp63 of keratinocytes would be effective for treatment of AD, because ΔNp63 works as a key molecule translating cellular insults into immune responses as well as barrier functions.